Patients with insulin-dependent diabetes (IDDM) possess antibodies to islet proteins of M(r)-64,000. Potential autoantigens of this M(r) include glutamate decarboxylase (GAD) and 65 kD heat shock protein. We have detected two distinct antibody specificities in IDDM that bind 50,000 M(r) or 37,000/40,000 M(r) proteolytic fragments of 64,000 M(r) proteins. In this study, we investigated relationships of these proteolytic fragments to GAD and heat shock proteins. Polyclonal antibodies to GAD bound 50,000 M(r) fragments of islet antigen. Recombinant GAD65, but not GAD67, blocked binding to this antigen, suggesting that 50,000 M(r) fragments are derived from islet GAD65. In contrast, GAD antibodies did not recognize 37,000/40,000 M(r) fragments, and neither GAD isoforms blocked autoantibody binding to precursors of these fragments. The 37,000/40,000 M(r) fragments, but not the 50,000 M(r) fragments, were detected after trypsin treatment of immunoprecipitates from insulinoma cells that lacked expression of major GAD isoforms. Antibodies in IDDM did not bind native or trypsinized islet heat shock proteins. Thus, IDDM patients possess antibodies to GAD, but also distinct antibodies to a 64,000 M(r) protein that is not related to known GAD isoforms or heat shock proteins.
M R Christie, J A Hollands, T J Brown, B K Michelsen, T L Delovitch
Title and authors | Publication | Year |
---|---|---|
Harmonization of immunoassays for biomarkers in diabetes mellitus
S Hörber, P Achenbach, E Schleicher, A Peter |
Biotechnology Advances | 2019 |
Islet inflammation in human type 1 diabetes mellitus: Process of Islet Inflammation in Human T1DM
NG Morgan, P Leete, AK Foulis, SJ Richardson |
IUBMB Life | 2014 |
Proteomic and Metabolomic Approaches to Biomarker Discovery
J Qiu, KS Anderson |
Proteomic and Metabolomic Approaches to Biomarker Discovery | 2013 |
Autoanticorpi nel diabete mellito
A Falorni, V Minarelli |
La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine | 2013 |
Inverse vaccination with islet autoantigens to halt progression of autoimmune diabetes
SA Hinke |
Drug Development Research | 2011 |
Islet protein profiling
P Bergsten |
Diabetes, Obesity and Metabolism | 2009 |
Deleting islet autoimmunity
E Liu, M Li, J Jasinski, M Kobayashi, R Gianani, M Nakayama, GS Eisenbarth |
Cell Biochemistry and Biophysics | 2007 |
Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus
J Kis, P Engelmann, K Farkas, G Richman, S Eck, J Lolley, H Jalahej, M Borowiec, SC Kent, A Treszl, T Orban |
Journal of leukocyte biology | 2006 |
Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies
B Franke, TS Galloway, TJ Wilkin |
Diabetes/Metabolism Research and Reviews | 2005 |
Diabetes-related antibodies in adult diabetic patients
A Falorni, A Brozzetti |
Best Practice & Research Clinical Endocrinology & Metabolism | 2005 |
Endocrine autoantibodies
D Devendra, L Yu, GS Eisenbarth |
Clinics in Laboratory Medicine | 2004 |
International Textbook of Diabetes Mellitus
RA DeFronzo, L Mandarino, E Ferrannini |
International Textbook of Diabetes Mellitus | 2003 |
Pediatric Diabetes
RK Menon, MA Sperling |
Pediatric Diabetes | 2003 |
Current Protocols in Protein Science
SJ Bauman, HC Whinna, FC Church |
Current Protocols in Protein Science | 2002 |
Molecular Mechanisms Involved in the Etiopathogenesis of Malnutrition-Modulated Diabetes Mellitus
A Kanungo, KC Samal, CB Sanjeevi |
Annals of the New York Academy of Sciences | 2002 |
Autoantibodies to Pancreatic hsp60 Precede the Development of Glucose Intolerance in Patients with Cystic Fibrosis
P Jensen, HK Johansen, P Carmi, N Høiby, IR Cohen |
Journal of Autoimmunity | 2001 |
Autoantibodies to IA-2 in insulin-dependent diabetes mellitus Measurements with a new immunoprecipitation assay
M Masuda, M Powell, S Chen, C Beer, P Fichna, BR Smith, J Furmaniak |
Clinica Chimica Acta | 2000 |
Clinical Evaluation of a Radioimmunoprecipitation Assay for IA-2 Antibody and Comparison of GAD Antibody in Type 1 Diabetes Mellitus
M Ohta, K Ohta, H Obayashi, N Nakamura, H Shlgeta, K Nakano, G Hasegawa, M Fukui, Y Kitagawa, M Nishimura, N Itoh |
Autoimmunity | 2000 |
The use of islet autoantibody markers in the prediction of autoimmune type 1 diabetes
WE Winter |
Clinical Immunology Newsletter | 1999 |
Répertoire des autoanticorps: application au diabète de type 1
AM Madac, A Mayer, F Raharbaoui |
Immuno-analyse & Biologie Spécialisée | 1999 |
Autoimmune Diabetes: The Role of T Cells, MHC Molecules and Autoantigens
I Durinovic-Bello |
Autoimmunity | 1998 |
Expression, characterization, processing and immunogenicity of an insulin-dependent diabetes mellitus autoantigen, IA-2, in Sf-9 cells
H Xie, YJ Deng, AL Notkins, MS Lan |
Clinical & Experimental Immunology | 1998 |
Endocrine Autoimmunity and Associated Conditions
AP Weetman |
1998 | |
Cross reactivity between IA-2 and phogrin/IA-2β in binding of autoantibodies in IDDM
EC Hatfield, CJ Hawkes, MA Payton, MR Christie |
Diabetologia | 1997 |
Islet Cell Antigens in the Prediction and Prevention of Insulin-dependent Diabetes Mellitus
E Bonifacio, MR Christie |
Annals of Medicine | 1997 |
Antibodies to the Tyrosine Phosphatase-like Protein IA-2 are highly associated with IDDM, but not with Autoimmune Endocrine Diseases or Stiff Man Syndrome
NG Morgenthaler, J Seissler, P Achenbach, D Glawe, M Payton, HM Meinck, MR Christie, WA Scherbaum |
Autoimmunity | 1997 |
An islet-cell protein tyrosine phosphatase is a likely precursor to the 37-kDa autoantigen in type 1 diabetes: human and macaque sequences, tissue distribution, unique and shared epitopes, and predictive autoantibodies
J LaGasse, L Jelinek, S Sexson, C Lofton-Day, J Breininger, P Sheppard, W Kindsvogel, WA Hagopian |
Molecular Medicine | 1997 |
Advances in Molecular and Cell Biology
KJ Clemetson |
Advances in Molecular and Cell Biology | 1997 |
Enzyme-Linked Immunosorbent Assay of Autoantibodies against Mitochondrial Glycerophosphate Dehydrogenase in Insulin-Dependent and Non-Insulin-Dependent Diabetic Subjects
ME Fabregat, C Benito, M Gudayol, J Vidal, T Gallart, WJ Malaisse, R Gomis |
Biochemical and Molecular Medicine | 1997 |
Autoimmune Diabetes
DV House, WE Winter |
Clinics in Laboratory Medicine | 1997 |
Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient
SD Arden, BO Roep, PI Neophytou, EF Usac, G Duinkerken, RR de Vries, JC Hutton |
Journal of Clinical Investigation | 1996 |
Islet cell autoantigens in type 1 diabetes
MR Christie |
European Journal of Clinical Investigation | 1996 |
Antigenic determinants in type 1 diabetes mellitus:
F Dotta, U Mario |
APMIS | 1996 |
The Use of Immunological Markers in IDDM After More Than 20 Years From ICA Description
F Dotta, I Dionisi, L Farilla, UD Mario |
Diabetes/Metabolism Reviews | 1996 |
Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment
J Lu, Q Li, H Xie, ZJ Chen, AE Borovitskaya, NK Maclaren, AL Notkins, MS Lan |
Proceedings of the National Academy of Sciences | 1996 |
The nature of autoantigens targeted in autoimmune endocrine diseases
YH Song, Y Li, NK Maclaren |
Immunology Today | 1996 |
Cloning and Characterization of Islet Cell Antigen-related Protein-tyrosine Phosphatase (PTP), a Novel Receptor-like PTP and Autoantigen in Insulin-dependent Diabetes
L Cui, WP Yu, HJ DeAizpurua, RS Schmidli, CJ Pallen |
The Journal of biological chemistry | 1996 |
Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512)
MA Payton, CJ Hawkes, MR Christie |
Journal of Clinical Investigation | 1995 |
Pathogenesis of insulin-dependent diabetes mellitus
A Falorni, I Kockum, CB Sanjeevi, Lernmark |
Baillière's Clinical Endocrinology and Metabolism | 1995 |
Insulin-dependent diabetes mellitus as a ?-cell targeted disease of immunoregulation
JF Bach |
Journal of Autoimmunity | 1995 |
Self and non-self antigen in diabetic autoimmunity: Molecules and mechanisms
WJ Karges, J Ilonen, BH Robinson, HM Dosch |
Molecular Aspects of Medicine | 1995 |
Glutamic acid decarboxylase and other autoantigens in IDDM
GT Nepom |
Current Opinion in Immunology | 1995 |
Brain-reactive autoantibodies in BB/d rats do not recognize glutamic acid decarboxylase
C Davenport, H Lovell, RF James, I Todd |
Clinical & Experimental Immunology | 1995 |
The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2
N Passini, JD Larigan, S Genovese, E Appella, F Sinigaglia, L Rogge |
Proceedings of the National Academy of Sciences | 1995 |
Les autoanticorps associés au développement du diabète insulinodépendant
F Rharbaoui, C Granier, B Pau, M Bouanani |
Immuno-analyse & Biologie Spécialisée | 1995 |
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
FH Epstein, MA Atkinson, NK Maclaren |
New England Journal of Medicine | 1994 |
Autoantibodies in insulin-dependent diabetes mellitus
E Bosi, E Bonifacio |
Journal of Endocrinological Investigation | 1994 |
Autoantigens in type 1 diabetes mellitus
F Dotta, E Anastasi, C Tiberti, UD Mario |
Journal of Endocrinological Investigation | 1994 |
Prediction and prevention of type I diabetes
R Gianani, GS Eisenbarth |
Journal of Endocrinological Investigation | 1994 |
Molecular Biology of Diabetes
B Draznin, D LeRoith |
1994 | |
Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease
R Wagner, S Genovese, E Bosi, F Becker, PJ Bingley, E Bonifacio, KA Miles, MR Christie, GF Bottazzo, EA Gale |
Diabetologia | 1994 |
T-cell reactivity to 38 kD insulin-secretory granule protein in patients with recent onset type 1 diabetes
BO Roep, AA Kallan, WL Hazenbos, JG Bruining, EM Bailyes, SD Arden, JC Hutton, RR Vries, E Bonifacio, C Boitard |
Journal of Endocrinological Investigation | 1994 |
Molecular biology of IDDM.
Lernmark A |
Diabetologia | 1994 |